Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes
Open Access
- 9 July 2025
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (9) , 2226-2232
Abstract
Background: The rapid evolution of cardiac implantable electronic devices (CIEDs) has increased remote transmission data, leading to excessive non‐actionable alerts (NAA) and alert fatigue.Objective: Optimize alert parameters to minimize NAA and evaluate the impact on clinical outcomes.Methods: We included 536 participants (mean age 75 (15) years, 60.4% male, 83.4% white) with CIEDs. In 413 patients, CIEDs were reprogrammed to censor alerts as follows: atrial fibrillation (AF) episodes < 5.5 h, persistent AF > 1 month with prior alerts, AF < 24 h on anticoagulation or with prior appendage occlusion, and non‐sustained ventricular tachycardia (NSVT) in defibrillator platforms. NAAs were tracked 90‐days pre‐ and post‐reprogramming. Incident ischemic stroke and sudden cardiac death (SCD) were assessed over a median 1.8‐year follow‐up. Logistic regression models examined associations between reprogramming and outcomes.Results: Reprogramming was implemented for AF alerts (69.5%, n = 287) and NSVT alerts (30.5%, n = 126). After reprogramming, NAAs significantly decreased from 6.68 (SD = 10.02) to 2.27 (SD = 4.58), p < 0.001. During follow‐up, ischemic stroke rates in AF patients were similar between reprogrammed (5.2%, n = 15) and control groups (5.4%, n = 5). In those with NSVT alerts, SCD incidence was lower in reprogrammed (2.3%, n = 3) versus controls (9.3%, n = 3). In logistic regression models adjusted for demographics, CHA₂DS₂VASC score, anticoagulation status, and prior stroke history, there was no statistically significant difference in stroke risk between groups (OR 0.82 [0.27–2.51]).Conclusions: Guideline‐based alert parameters in CIED patients significantly reduced NAA burden with no increasing in adverse outcomes in patients with device‐detected AF or NSVT alerts. This approach may reduce noise and safely improve efficiency.Keywords
This publication has 26 references indexed in Scilit:
- Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesNew England Journal of Medicine, 2023
- Filtering of remote monitoring alerts transmitted by cardiac implantable electronic devices and reclassification of atrial fibrillation events by a new algorithmCardiovascular Digital Health Journal, 2023
- Data deluge from remote monitoring of cardiac implantable electronic devices and importance of clinical stratificationHeart Rhythm O2, 2023
- Remote Patient Monitoring: What Have We Learned and Where Are We Going?Current Cardiovascular Risk Reports, 2023
- HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devicesHeart Rhythm, 2015
- The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator PatientsJACC, 2015
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trialThe Lancet, 2014
- Prognostic Significance of Ambulatory ECG Monitoring for Ventricular ArrhythmiasProgress in Cardiovascular Diseases, 2013
- Nonsustained Ventricular TachycardiaJACC, 2012
- The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) TrialJACC, 2011